How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

July 13, 2026

Amidst heatwave across Europe, ECDC launches improved tool for monitoring the risk of infection in coastal waters

Vibrio bacteria occur naturally in coastal waters, especially where it is warm and there is

July 13, 2026 No Comments

Hantavirus outbreak offers lessons for the next pandemic

A new analysis concludes that the hantavirus outbreak which killed three people aboard a cruise

July 13, 2026 No Comments

Early Release – Novel Parvovirus in Pigs Associated with Exophthalmos and Erythema, the Netherlands – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

July 13, 2026 No Comments

Engineered bacteria can deliver antiviral therapies, vaccines

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can

July 13, 2026 No Comments

Early Release – Lactococcus garvieae – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Figure Figure. Manor House on the 350-acre Shinfield Manor estate, which later became home to the National Institute for

July 13, 2026 No Comments

Early Release – Qualitative Risk Assessment of Infectious Agents Associated with Canine Importation into Canada, 2023–2024 – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

July 13, 2026 No Comments

Amidst heatwave across Europe, ECDC launches improved tool for monitoring the risk of infection in coastal waters

Hantavirus outbreak offers lessons for the next pandemic

Early Release – Novel Parvovirus in Pigs Associated with Exophthalmos and Erythema, the Netherlands – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Engineered bacteria can deliver antiviral therapies, vaccines

Early Release – Lactococcus garvieae – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Early Release – Qualitative Risk Assessment of Infectious Agents Associated with Canine Importation into Canada, 2023–2024 – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us